Guidance

Notification and management of medicines shortages: BGMA

Best practice guidelines to help minimise the possible problems of a medicine shortage.

This publication was withdrawn on

This guidance is no longer current. Updated guidance on reporting requirements for medicine shortages and discontinuations was published on 20 March 2019.

Documents

Details

The Department of Health (DH) and the British Generic Manufacturers Association (BGMA), who produced these guidelines, want companies to get in touch with DH as soon as possible about coming medicine shortages that might have an impact on patient care. This will allow the DH and the industry to work together to manage the shortage and to make back-up arrangements where they are needed.

Published 15 January 2007